Your browser is old and is not supported. Upgrade for better security.
Wefunder logo

Invest in Herbal Botanical Products, LLC

We formulate and sell topical pain management products infused with CBD isolate, Nano CBD, and CBG

EARLY BIRD TERMS: $249,900 LEFT

$100

reserved of a $50,000 goal
INVESTMENT TERMS
 $12.5M  $9.375M pre-money valuation Priced Round
Early Bird Bonus: The first $250K of investments will be at $75 per share and a $9.375M pre-money valuation
$250, $500, $750, $1K, $2.5K, $5K, $7.5K, $10K
LEAD INVESTOR
I chose to invest in Herbal Botanical Products LLC because of the solid management team and the potential of the industry. Based on the information I have collected, the industry is about to explode. It is also important for me to see products that are helping people with crippling pain and anxiety and would like a natural remedy. Both of my parents had chronic pain. My father due to an automobile accident,.and my mother from knee surgery, and Herbal Botanical's products have helped them both immensely managing their pain and getting back to physical activity. I also have used their products to assist me with sleep and stress and the the use of these products, for me,. has been life-changing.  Hopefully everyone can experience what I have with Herbal Botanical.

Highlights

1
Proven Leadership Team with over $100 million raised
2
Exploding Demand in a Fast-Growing Industry
3
High Operating Margins and Strong Financial Leadership
4
Highly Effective and Potent Product Set
5
Key Celebrity Endorsements and Partnerships

Our Team

After two successful exits (one for $45 million and another for $55 million), I was looking for the next best thing and a friend asked me to audit a CBD company he had invested in which is how I came to learn about the products, the inherent efficacy of the compounds, and the product margins.

Fast Facts


Herbal Botanical Products, LLC develops proprietary topical pain products infused with a combination of cannabinoids including CBD, CBG, CBN and select terpenes derived from the Cannabis Sativa L industrial hemp plant. Our customers use our topical pain products to help to manage a wide variety of chronic pain issues.

Key Highlights

We operate under the brand name Theá Panakeia Botanicals. In Greek mythology, Panakeia was the goddess of natural remedies in Greek mythology, where she would treat people with natural potions & poultices to heal people.

Because of the superior quality and effectiveness of our topical pain management products, we were selected to participate in Kevin Harrington’s Health & Wellness market campaign on Connected TV in 2020, through his company Shark Discoveries and As Seen on TV. We have also been offered the opportunity to be a Platinum Marketing Partner with The Arthritis Foundation, with access to their 600,000+ Members.

The Beginning

Herbal Botanical Products, LLC (“The Company”) is a Wyoming Limited Liability Company, formed to execute a Cannabinoid product set formulation and distribution business plan.

The Company entered the CBD product space by buying the inventory and Intellectual Property from the Bankruptcy Estate of Neuro-Endoceuticals, LLC, Case Number 6:19-bk-05180-KSJ in the Southern District of Florida.. In that Bankruptcy Estate, the Company bought the secured debt and became a UCC secured creditor. As a result, the Company is in possession of the physical assets of the estate, which are securely stored in a warehouse in St. Louis, MO and Oklahoma City, OK.

The assets acquired include, 22,000 containers and caps/lids, significant CBD isolate and CBD finished goods, a substantial amount of other supplement inventory including over 350 pounds of Telomere, Neuropathy, and Collagen powder, which can be emulsified with a carrier oil and infused into other topical products. We have sufficient raw material to infuse approximately 200,000 1-ounce servings, none of which is included in our revenue projections.

The Company also has CBD finished goods inventory that will sell at a Suggested Retail Price in excess of $100,000. In total, The Company has finished goods and raw materials inventory that could generate in excess of $5,000,000 in revenue.

The Company’s products have been completely vetted with The Arthritis Foundation and the Company has been offered the opportunity to become a Platinum Partner, complete with co-branding rights (participation in this program will be part of the Use of Cash from this offering). We are also an advertising partner with Villages-News.com whose digital marketing assets serve The Villages in Florida, which is the largest senior living development in the United States with almost 150,000 residents, all of whom are 50 plus. In addition, the Company has partnered with DMDatabase.com for pain sufferers email addresses and has access to over 17 million such addresses for email marketing purposes. The Company already owns a database of 50,000 such addresses.

Customers who have chronic pain issues, arthritis patients, and physical therapy patients. Typically, the target customer is 55 or older of which there are over 55 million in the United States alone.

Patents/IP

All of the pain product formulas are proprietary to the company.

Manufacturing

The Company is transitioning all product formulation and manufacturing to Kavana Health as a strategic partner. Using their 33,000 square foot facility in Oklahoma City, OK we will have better control over the quality and efficacy of products as well as just-in-time ordering and fulfillment and reducing time to market for new products and/or formulation. With this facility being in the center of the United States, fulfillment to either coast and points in between should be within two business days.

Market Opportunity

Target Customer

Customers who have chronic pain issues, arthritis patients, and physical therapy patients. Typically, the target customer is 55 or older of which there are over 55 million in the United States alone.

Market Size

The global chronic pain treatment market was valued at $77.8 billion in 2019 and is expected to grow at a 6.5% CAGR between 2020 and 2030. The chronic pain treatment industry is booming due to increasing government support for chronic pain treatment, the growing geriatric population, and the rising prevalence of chronic health conditions. The market size for topical pain products is $2.5 billion and is expected to grow at a 6% CAGR. Additionally, the CBD market is expected to exceed 56 billion by 2028

Growth Roadmap


    Go to Market Plan

    • Omnichannel Digital Marketing using Connected TV, Banner Ads, and Email targeting active senior living communities beginning with The Villages in Florida.
    • Arthritis Foundation sponsorship.
    • Social media marketing.
    • Retail and vertical market dealer channel development.


Future Products

Formulated and awaiting funding to place inventory order for:

  • 2500mg Transdermal Arthritis Pain Cream utilizing ALL nanosized CBD and terpenes
  • 2000mg Transdermal Gout Pain Balm with 1000mg CBD isolate and 1000mg CBG isolate for rapid onset


Future Products

Formulated and awaiting funding to place inventory order for:

  • 2500mg Transdermal Arthritis Pain Cream utilizing ALL nanosized CBD and terpenes
  • 2000mg Transdermal Gout Pain Balm with 1000mg CBD isolate and 1000mg CBG isolate for rapid onset

Exit Strategy

It is anticipated that the wave of consolidation will manifest as customer acceptance of CBD products strengthens and market growth takes hold. We will be actively seeking a merger partner to expand the size, scale & scope of a combined operation. When this occurs, our EBITDA should expand given the outsized gross margins the Company's product generates, thereby creating an exit avenue to a liquidity event.

Capital Plan

Initial Funding Round(s) – Thus far the total capital either raised or committed totals $760,583. This capital has been used to extract the assets from the referenced two bankruptcy estates, funded operation since 2020 (through the Pandemic), funded product formulation(s), purchased inventory, paid for the development of the Harrington marketing assets, funded this Crowdfunding expenses, and other developmental activities. This funding came from management and a small select group of investors who, for the most part have been in multiple transactions together in the past.

Crowdfunding Round-1 – This Crowdfunding round is the first time the Company has extended participation beyond its core group of investors. The terms of this round are designed to return the principal amount to the Crowd, with an attractive guaranteed cash-on-cash return and significant product perks over the course of a two-year horizon.


What’s Next
– After the CF-1 is complete, we will seek to grow revenue and put a revenue-based credit facility in place. Additionally, we will actively seek a merger partner to achieve greater scope and scale as we look to monetize the company in an approximated five-year time horizon.

Overview